购物车
- 全部删除
- 您的购物车当前为空
Anti-VCAM-1 Antibody-APC (5S896) 是一种 APC-conjugated Rabbit 抗体,靶向 VCAM-1。Anti-VCAM-1 Antibody-APC (5S896) 可用于 FCM。
Anti-VCAM-1 Antibody-APC (5S896) 是一种 APC-conjugated Rabbit 抗体,靶向 VCAM-1。Anti-VCAM-1 Antibody-APC (5S896) 可用于 FCM。
产品描述 | Anti-VCAM-1 Antibody-APC (5S896) is a APC-conjugated Rabbit antibody targeting VCAM-1. Anti-VCAM-1 Antibody-APC (5S896) can be used in FCM. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 5S896 |
交叉反应 | Human |
验证活性 | Flow cytometric analysis of Human VCAM1 expression on HUT78 cells. Cells were stained with APC-conjugated anti-Human VCAM1. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. |
应用 | FCM |
推荐剂量 | 5 μl/Test, 0.1 mg/ml |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Human VCAM-1 / CD106 (rh VCAM-1 / CD106; NP_001069.1Met1-Pro697) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
研究背景 | Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | APC |
其他可选修饰符 | Unconjugated/FITC/PE |
可提供抗体种类 | 4 |
免疫原 | Recombinant Human VCAM-1 / CD106 Protein |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
运输方式 | Shipping with blue ice. |
评论内容